| Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom R Kerslake, M Hall, HS Randeva, DA Spandidos, K Chatha, I Kyrou, ... International journal of molecular medicine 46 (3), 949-956, 2020 | 45 | 2020 |
| A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer R Kerslake, M Hall, P Vagnarelli, J Jeyaneethi, HS Randeva, G Pados, ... Oncology letters 22 (3), 1-14, 2021 | 28 | 2021 |
| COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease P Katopodis, R Kerslake, J Davies, HS Randeva, K Chatha, M Hall, ... International journal of molecular medicine 47 (4), 1-7, 2021 | 28 | 2021 |
| p38β-MAPK11 and its role in female cancers P Katopodis, R Kerslake, A Zikopoulos, N Beri, V Anikin Journal of Ovarian Research 14 (1), 84, 2021 | 18 | 2021 |
| Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer R Kerslake, C Sisu, S Panfilov, M Hall, N Khan, J Jeyaneethi, H Randeva, ... Journal of Clinical Medicine 11 (19), 5942, 2022 | 9 | 2022 |
| Impact of Environmentally Relevant Concentrations of Bisphenol A (BPA) on the Gene Expression Profile in an In Vitro Model of the Normal Human Ovary A Zahra, R Kerslake, I Kyrou, HS Randeva, C Sisu, E Karteris International Journal of Molecular Sciences 23 (10), 5334, 2022 | 8 | 2022 |
| Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models R Kerslake, B Belay, S Panfilov, M Hall, I Kyrou, HS Randeva, J Hyttinen, ... Cancers 15 (13), 3350, 2023 | 5 | 2023 |
| Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs R Kerslake, HS Randeva, D Jonigk, C Werlein, JL Robertus, P Katopodis, ... Molecular medicine reports 25 (4), 1-6, 2022 | 5 | 2022 |
| Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer R Kerslake, S Panfilov, N Mustafa, M Hall, I Kyrou, HS Randeva, ... Journal of Clinical Medicine 12 (1), 217, 2022 | 3 | 2022 |
| ACBD3 bioinformatic analysis and protein expression in breast cancer cells J Houghton-Gisby, R Kerslake, E Karteris, K Mokbel, AJ Harvey MDPI, 2022 | 3 | 2022 |
| Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro A Filipe, P Katopodis, D Chudasama, R Kerslake, J Jeyaneethi, V Anikin, ... Journal of personalized medicine 12 (2), 201, 2022 | 2 | 2022 |
| Investigation of the role of asprosin and downstream glycolytic molecules in ovarian cancer R Kerslake Brunel University London, 2023 | | 2023 |
